Detalles de la búsqueda
1.
A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors.
Anticancer Drugs
; 35(5): 450-458, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38452059
2.
Take me to your leader: Reporting structures and equity in academic gynecologic oncology.
Gynecol Oncol
; 157(3): 759-764, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32276792
3.
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.
Gynecol Oncol
; 154(2): 420-425, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31229298
4.
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer.
BMC Cancer
; 18(1): 1292, 2018 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30591028
5.
Treatment-Related Radiation Toxicity Among Cervical Cancer Patients.
Int J Gynecol Cancer
; 28(7): 1387-1393, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30036222
6.
Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients.
J Proteome Res
; 14(4): 1900-10, 2015 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25748058
7.
A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 138(1): 30-5, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25887099
8.
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
Gynecol Oncol
; 134(3): 478-85, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25016924
9.
Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study.
Gynecol Oncol
; 119(3): 444-50, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20846715
10.
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.
Clin Cancer Res
; 26(5): 1009-1016, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31831561
11.
Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study.
Gynecol Oncol
; 114(3): 472-9, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19524285
12.
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study.
Gynecol Oncol
; 113(3): 341-7, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19272639
13.
Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer.
Gynecol Oncol Rep
; 28: 116-119, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31011609
14.
Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma.
Am J Clin Oncol
; 42(8): 649-654, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31305287
15.
Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers A Gynecologic Oncology Group study.
Gynecol Oncol
; 111(3): 487-95, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18834621
16.
HE4--another marker for gynecologic cancers: do we really need one?
Oncology (Williston Park)
; 27(6): 563, 566, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23909071
17.
Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future.
Front Oncol
; 7: 177, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28871275
18.
Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line.
Hum Cell
; 30(3): 226-236, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28251557
19.
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
Oncotarget
; 7(14): 17290-300, 2016 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26981780
20.
The afatinib resistance of in vivo generated H1975 lung cancer cell clones is mediated by SRC/ERBB3/c-KIT/c-MET compensatory survival signaling.
Oncotarget
; 7(15): 19620-30, 2016 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26934000